Medical - Diagnostics & Research · NASDAQ
当前价格
$573.82
内在价值
使用下方计算器估算
对 IDEXX Laboratories, Inc. 运行完整的 DCF 分析，自动填充基本面数据，可调节假设参数，含敏感性热力图。
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
ROIC (TTM)
40.3%
ROE (TTM)
69.8%
FCF Yield
2.30%
基于过去 12 个月的数据，IDXX 每股自由现金流为 N/A，投入资本回报率（ROIC）为 40.3%，这些是使用 DCF 方法进行股票估值的关键输入。P/FCF 比率为 N/A，FCF 收益率为 2.30%，是评估 IDXX 相对估值的重要参考指标。
IDXX 的内在价值取决于对未来增长率、折现率（WACC）和终值的假设。使用 MiniValuator 免费 DCF 计算器，输入你自己的假设进行估算，并查看敏感性分析热力图。
IDXX 是否被低估取决于你的 DCF 假设。如果计算出的内在价值显著高于当前市价，则可能被低估。安全边际指示低估程度。在 MiniValuator 上运行完整估值来了解。
你可以使用 MiniValuator 的 DCF 计算器对 IDXX 估值：输入代码，查看自动填充的基本面数据，调整增长率和折现率假设，即可获得含敏感性热力图的即时内在价值。
DCF（折现现金流）估值通过将公司未来预期自由现金流折现回现值来估算内在价值。对于 IDXX，你输入预期增长率和折现率（WACC），模型会根据其未来现金产生能力计算股票当前应有的价值。
WACC（加权平均资本成本）是 IDXX 估值中使用的折现率。较高的 WACC 会降低内在价值估算，较低的 WACC 则会提高。使用 MiniValuator 的敏感性热力图查看不同 WACC 假设对 IDXX DCF 估值结果的影响。
